Literature DB >> 17846378

Postoperative vancomycin-resistant Enterococcus faecium endophthalmitis.

Harshivinderjit S Bains1, David V Weinberg, Robert S Feder, Gary A Noskin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17846378     DOI： 10.1001/archopht.125.9.1292

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  18 in total

1.  Severe bacterial endophthalmitis: towards improving clinical outcomes.

Authors:  Billy D Novosad; Michelle C Callegan
Journal:  Expert Rev Ophthalmol       Date:  2010-10

2.  Susceptibility of bacterial isolates to vancomycin and ceftazidime from patients with endophthalmitis: Is there a need to change the empirical therapy in suspected bacterial endophthalmitis?

Authors:  Ashok Kumar Reddy; Raja Rami Reddy; Muralidhar Rao Paruvelli; Srinivas Ambatipudi; Alka Rani; Sikander A K Lodhi; Juturi Maruthi Lokabhi Reddy; K Ramakanth Reddy; Niraj Pandey; Rituraj Videkar; Manish Kumar Sinha; Ajit Babu Majji; Nilanjana Deb-Jorder; Atul Kumar Sahu; Jyostna Myneni; Anina Abraham
Journal:  Int Ophthalmol       Date:  2014-11-11       Impact factor: 2.031

3.  Therapeutic Effects of Intravitreously Administered Bacteriophage in a Mouse Model of Endophthalmitis Caused by Vancomycin-Sensitive or -Resistant Enterococcus faecalis.

Authors:  Tatsuma Kishimoto; Waka Ishida; Ken Fukuda; Isana Nakajima; Takashi Suzuki; Jumpei Uchiyama; Shigenobu Matsuzaki; Daisuke Todokoro; Masanori Daibata; Atsuki Fukushima
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

4.  Ocular penetration of topically applied 1% tigecycline in a rabbit model.

Authors:  Yasar Sakarya; Rabia Sakarya; Muammer Ozcimen; Sertan Goktas; Serap Ozcimen; Ismail Alpfidan; Ismail Senol Ivacık; Erkan Erdogan; Servet Cetinkaya; Abdulkadir Bukus
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

5.  Intravitreal daptomycin: a safety and efficacy study.

Authors:  Grant M Comer; John B Miller; Eric W Schneider; Naheed W Khan; David M Reed; Victor M Elner; David N Zacks
Journal:  Retina       Date:  2011-06       Impact factor: 4.256

Review 6.  Antimicrobial guide to posterior segment infections.

Authors:  Tapan P Patel; David N Zacks; Vaidehi S Dedania
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-11-06       Impact factor: 3.117

7.  Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives.

Authors:  M Kernt; A Kampik
Journal:  Clin Ophthalmol       Date:  2010-03-24

Review 8.  Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment.

Authors:  Nidhi Relhan; Thomas A Albini; Avinash Pathengay; Ajay E Kuriyan; Darlene Miller; Harry W Flynn
Journal:  Br J Ophthalmol       Date:  2015-12-23       Impact factor: 4.638

9.  Enterococcus faecalis Endophthalmitis: Clinical Settings, Antibiotic Susceptibility, and Management Outcomes.

Authors:  Kuan-Jen Chen; Chi-Chun Lai; Hung-Chi Chen; Ying-Jiun Chong; Ming-Hui Sun; Yen-Po Chen; Nan-Kai Wang; Yih-Shiou Hwang; An-Ning Chao; Wei-Chi Wu; Ling Yeung; Chi-Chin Sun; Laura Liu; Yi-Hsing Chen; Hung-Da Chou
Journal:  Microorganisms       Date:  2021-04-24

10.  Vancomycin-resistant Gram-positive bacterial endophthalmitis: epidemiology, treatment options, and outcomes.

Authors:  Manav Khera; Avinash Pathengay; Animesh Jindal; Subhadra Jalali; Annie Mathai; Rajeev Reddy Pappuru; Nidhi Relhan; Taraprasad Das; Savitri Sharma; Harry W Flynn
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.